Evidence map›Paper›PMID 29488120›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2018

Are animals a source of Stenotrophomonas maltophilia in human infections? Contributions of a nationwide molecular study.

Aurélie Jayol, Camille Corlouer, Marisa Haenni, Mélanie Darty, Karine Maillard, Marine Desroches, Brigitte Lamy, Estelle Jumas-Bilak, Jean-Yves Madec, Jean-Winoc Decousser

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. First Report ofAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Phage P2-71 against multi-drug resistantFrontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. First Report ofLife (Basel, Switzerland) · 2023
    Article
  7. Clinical challenges treatingJAC-antimicrobial resistance · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Aurélie JayolLaboratory of Bacteriology and Infection Control, Department of Microbiology, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, 94000, Créteil, France.
Camille CorlouerLaboratory of Bacteriology and Infection Control, Department of Microbiology, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, 94000, Créteil, France.
Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, ANSES, Lyon, France.
Mélanie DartyNext Generation Sequencing Platform, University Hospital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
Karine MaillardLaboratoire Labeo Frank Duncombe, Caen, France.
Marine DesrochesLaboratory of Bacteriology and Infection Control, Department of Microbiology, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, 94000, Créteil, France.
Brigitte LamyDepartment of Bacteriology, Archet 2 Hospital, Nice Academic Hospital, Nice, France.
Estelle Jumas-BilakInfection Control Department, Montpellier University Hospital, Montpellier, France.
Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes, ANSES, Lyon, France.
Jean-Winoc DecousserLaboratory of Bacteriology and Infection Control, Department of Microbiology, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, 94000, Créteil, France. jean-winoc.decousser@hmn.aphp.fr.
Assistance Publique – Hôpitaux de Paris · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRÉcole Nationale Vétérinaire d'Alfort · FRHôpital l'Archet · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stenotrophomonas maltophilia (Sm) is an archetypal environmental opportunistic bacterium responsible for health care-associated infections. The role of animals in human Sm infections is unknown. This study aims to reveal the genetic and phylogenetic relationships between pathogenic strains of Sm, both animal and human, and identify a putative role for animals as a reservoir in human infection. We phenotypically and genotypically characterized 61 Sm strains responsible for animal infections (mainly respiratory tract infections in horses) from a French nationwide veterinary laboratory network. We tested antimicrobial susceptibility and performed MLST and genogrouping using the concatenation of the seven housekeeping genes from the original MLST scheme. Excluding the eight untypeable strains owing to the lack of gene amplification, only 10 out of the 53 strains yielded a known ST (ST5, ST39, ST162, ST8, ST27, ST126, ST131). The genogroup distribution highlighted not only genogroups (genogroups 5 and 9) comprised exclusively of animal strains but also genogroups shared by human and animal strains. Interestingly, these shared genogroups were primarily groups 2 and 6, which have previously been identified as the two most frequent genogroups among human-pathogenic Sm strains, especially among respiratory pathogens. The antimicrobial susceptibility testing underlined the presence of acquired resistance: 18.8 and 7.5% of the tested isolates were resistant to the sulfonamide-trimethoprim combination and ciprofloxacin, respectively. Animal strains of Sm shared phylogenetic traits with some of the most successful human strains. The exact relationships between the human and animal strains, and the genetic support of these common traits, need to be determined.

Indexed as

PhylogenyAnimalsAnti-Bacterial AgentsCross InfectionDisease ReservoirsGram-Negative Bacterial InfectionsHorsesHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPhenotypeRespiratory Tract DiseasesStenotrophomonas maltophiliaAnti-Bacterial Agents

Identifiers

PMID29488120
OpenAlexW2793385759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.